This year’s NVGCT Annual Symposium took place on November 9th and 10th 2021 at the conference center De Werelt in Lunteren. We would like to thank all participants and sponsors for their contribution. For a summary of this event, click here.
Intellia and Regeneron Announce Landmark Clinical Data Showing Deep Reduction in Disease-Causing Protein After Single Infusion of NTLA-2001, an Investigational CRISPR Therapy for Transthyretin (ATTR) Amyloidosis
Clinical development data update week 8 and 9
Clinical development data update week 7
Rob Collin benoemd tot hoogleraar Moleculaire therapie voor erfelijke netvliesaandoeningen – Radboudumc
29 januari 2021
Met ingang van 16 januari 2021 is moleculair geneticus Rob Collin benoemd tot hoogleraar ‘Moleculaire Therapie voor Erfelijke Netvliesaandoeningen’ aan de Radboud Universiteit/het Radboudumc.